Basic Atomic Physics

Contains reports on four research projects.Joint Services Electronics Program Contract DAAL03-92-C-0001National Science Foundation Grant PHY 89-19381U.S. Navy - Office of Naval Research Grant N00014-90-J-1322National Science Foundation Grant PHY 89-21769U.S. Army - Office of Scientific Research Contract DAAL03-89-K-0082U.S. Navy - Office of Naval Research Grant N00014-89-J-1207U.S. Navy - Office of Naval Research Grant N00014-90-J-164

Basic Atomic Physics

Contains reports on five research projects.National Science Foundation Grant PHY 89-19381U.S. Navy - Office of Naval Research Contract N00014-90-J-1322Joint Services Electronics Program Contract DAAL03-89-C-0001Joint Services Electronics Program Contract DAAL03-92-C-0001U.S. Army Research Office Contract DAAL03-89-K-0082U.S. Navy - Office of Naval Research Grant N00014-89-J-1207U.S. Navy - Office of Naval Research Grant N00014-90-J-1642National Science Foundation Grant PHY 86-05893National Science Foundation Grant PHY 89-2176

Basic Atomic Physics

Contains reports on five research projects.National Science Foundation Grant PHY 89-19381National Science Foundation Grant PHY 92-21489U.S. Navy - Office of Naval Research Grant N00014-90-J-1322Joint Services Electronics Program Contract DAAL03-92-C-0001National Science Foundation Grant PHY 89-21769U.S. Army - Office of Scientific Research Grant DAAL03-92-G-0229U.S. Navy - Office of Naval Research Grant N00014-89-J-1207U.S. Navy - Office of Naval Research Grant N00014-90-J-164

Basic Atomic Physics

Contains reports on five research projects.Joint Services Electronics Program Contract DAAL03-92-C-0001Joint Services Electronics Program Grant DAAH04-95-1-0038National Science Foundation Grant PHY 92-21489U.S. Navy - Office of Naval Research Grant N00014-90-J-1322National Science Foundation Grant PHY 92-22768U.S. Army - Office of Scientific Research Grant DAAL03-92-G-0229U.S. Army - Office of Scientific Research Grant DAAL01-92-6-0197U.S. Navy - Office of Naval Research Grant N00014-89-J-1207Alfred P. Sloan FoundationU.S. Navy - Office of Naval Research Grant N00014-90-J-1642U.S. Navy - Office of Naval Research Grant N00014-94-1-080

Small-Animal Imaging Using Clinical Positron Emission Tomography/Computed Tomography and Super-Resolution

Considering the high cost of dedicated small-animal positron emission tomography/computed tomography (PET/CT), an acceptable alternative in many situations might be clinical PET/CT. However, spatial resolution and image quality are of concern. The utility of clinical PET/CT for small-animal research and image quality improvements from super-resolution (spatial subsampling) were investigated. National Electrical Manufacturers Association (NEMA) NU 4 phantom and mouse data were acquired with a clinical PET/CT scanner, as both conventional static and stepped scans. Static scans were reconstructed with and without point spread function (PSF) modeling. Stepped images were postprocessed with iterative deconvolution to produce super-resolution images. Image quality was markedly improved using the super-resolution technique, avoiding certain artifacts produced by PSF modeling. The 2 mm rod of the NU 4 phantom was visualized with high contrast, and the major structures of the mouse were well resolved. Although not a perfect substitute for a state-of-the-art small-animal PET/CT scanner, a clinical PET/CT scanner with super-resolution produces acceptable small-animal image quality for many preclinical research studies

A novel PSMA-targeting tracer with highly negatively charged linker demonstrates decreased salivary gland uptake in mice compared to [68Ga]Ga-PSMA-11

Abstract Background The current generation of radiolabeled PSMA-targeting therapeutic agents is limited by prominent salivary gland binding, which results in dose-limiting xerostomia from radiation exposure. JB-1498 is a urea-based small molecule with a highly negatively charged linker targeting prostate specific membrane antigen (PSMA). Prior work on a similar tracer with the same negatively charged linker demonstrated low normal organ/soft tissue background uptake compared to [68Ga]Ga-PSMA-11. The purpose of this study was to investigate if [68Ga]Ga-JB-1498 had reduced salivary gland uptake in mice compared to [68Ga]Ga-PSMA-11. Results JB-1498 demonstrated high affinity for PSMA binding and tumor uptake in a murine tumor model. In an initial biodistribution study with low molar activity, [68Ga]Ga-JB-1498 demonstrated salivary gland uptake of 0.13 ± 0.01%ID/g. In a second biodistribution study in non-tumor-bearing mice with high molar activity, [68Ga]Ga-JB1498 demonstrated salivary gland uptake of 0.39 ± 0.24% ID/g and kidney activity of 10.12 ± 1.73% ID/g at one hour post IV injection. This salivary gland uptake is significantly less than the published uptake of [68Ga]Ga-PSMA-11. Micro-PET visually confirmed the findings of the biodistribution studies. Dynamic micro-PET imaging demonstrated gradually decreasing [68Ga]Ga-JB1498 activity in salivary glands and kidneys, compared to gradually increasing [68Ga]Ga-PSMA-11 activity in these two organs during the first hour. Conclusion Biodistribution and micro-PET imaging of [68Ga]Ga-JB-1498 demonstrate significantly decreased salivary gland uptake and different pharmacokinetic behavior in kidneys and salivary glands in mice compared to [68Ga]Ga-PSMA-11. Our findings suggest that constructing a PSMA-targeting molecule with a highly negatively charged linker is a promising strategy to reduce salivary gland uptake of GCP-II/PSMA ligands in theranostic applications

Quantification of SPECT Concentric Ring Artifacts by Radiomics and Radial Features

(1) Background: Concentric ring artifacts in reconstructed SPECT images indicate the presence of detector non-uniformity in gamma camera systems. The identification of these artifacts is generally visual and not quantitative. The aim of our study was to evaluate observer assessments of the presence of concentric rings in reconstructed SPECT phantom images and to verify whether quantitative texture analysis can detect such artifacts, which are detrimental to accurate tumor detection. (2) Methods: Test data were acquired as part of the quarterly quality assurance program using a standardized SPECT phantom containing solid spheres, solid rods, and a water solution of 99mTc. Forty separate SPECT acquisitions were analyzed to assess the presence of ring artifacts. Two experienced medical physicists independently reviewed transaxial images and graded the severity of artifacts on a five-point scale. Quantitative radiomic features were computed for volumes of interest located in the uniform phantom section. In addition to these, radial contrast (RContrast) and radial root-mean-square contrast (RRMSC) were also calculated and derived from the radial profile of summed slices transformed into polar coordinates. (3) Results: Artifacts were considered sufficiently severe to warrant camera re-tuning in 10 rod sections, 17 sphere sections, and 16 uniform sections. In the uniform sections, there was “good agreement” for inter-observer and intra-rater assessments (κ = 0.66, Fisher exact p < 0.0001 and κ = 0.61, and Fisher exact p = 0.001, respectively). The two radial features agreed significantly (p < 0.001) with visual severity judgment of ring artifacts in uniform sections and were selected as informative about the presence of ring artifacts by LASSO approach. The increased magnitude of RContrast and RRMSC correlated significantly with increasingly severe artifact scores (ρ = 0.65–0.66, p < 0.0001). (4) Conclusions: There was good agreement between the physicists with respect to the presence of circular ring artifacts in uniform sections of SPECT quality assurance scans, with the artifacts accurately detected by radial contrast and noise-to-signal ratio measurements

Quantification of SPECT Concentric Ring Artifacts by Radiomics and Radial Features

(1) Background: Concentric ring artifacts in reconstructed SPECT images indicate the presence of detector non-uniformity in gamma camera systems. The identification of these artifacts is generally visual and not quantitative. The aim of our study was to evaluate observer assessments of the presence of concentric rings in reconstructed SPECT phantom images and to verify whether quantitative texture analysis can detect such artifacts, which are detrimental to accurate tumor detection. (2) Methods: Test data were acquired as part of the quarterly quality assurance program using a standardized SPECT phantom containing solid spheres, solid rods, and a water solution of 99mTc. Forty separate SPECT acquisitions were analyzed to assess the presence of ring artifacts. Two experienced medical physicists independently reviewed transaxial images and graded the severity of artifacts on a five-point scale. Quantitative radiomic features were computed for volumes of interest located in the uniform phantom section. In addition to these, radial contrast (RContrast) and radial root-mean-square contrast (RRMSC) were also calculated and derived from the radial profile of summed slices transformed into polar coordinates. (3) Results: Artifacts were considered sufficiently severe to warrant camera re-tuning in 10 rod sections, 17 sphere sections, and 16 uniform sections. In the uniform sections, there was “good agreement” for inter-observer and intra-rater assessments (κ = 0.66, Fisher exact p p = 0.001, respectively). The two radial features agreed significantly (p RContrast and RRMSC correlated significantly with increasingly severe artifact scores (ρ = 0.65–0.66, p < 0.0001). (4) Conclusions: There was good agreement between the physicists with respect to the presence of circular ring artifacts in uniform sections of SPECT quality assurance scans, with the artifacts accurately detected by radial contrast and noise-to-signal ratio measurements

Determination of Radiation Absorbed Dose to Primary Liver Tumors and Normal Liver Tissue Using Post-Radioembolization (90)Y PET.

BACKGROUND: Radioembolization with Yttrium-90 ((90) Y) microspheres is becoming a more widely used transcatheter treatment for unresectable hepatocellular carcinoma (HCC). Using post-treatment (90) Y positron emission tomography/computerized tomography (PET/CT) scans, the distribution of microspheres within the liver can be determined and quantitatively assessed. We studied the radiation dose of (90) Y delivered to liver and treated tumors. METHODS: This retrospective study of 56 patients with HCC, including analysis of 98 liver tumors, measured and correlated the dose of radiation delivered to liver tumors and normal liver tissue using glass microspheres (TheraSpheres(®)) to the frequency of complications with modified response evaluation criteria in solid tumors (mRECIST). (90) Y PET/CT and triphasic liver CT scans were used to contour treated tumor and normal liver regions and determine their respective activity concentrations. An absorbed dose factor was used to convert the measured activity concentration (Bq/mL) to an absorbed dose (Gy). RESULTS: The 98 studied tumors received a mean dose of 169 Gy (mode 90-120 Gy; range 0-570 Gy). Tumor response by mRECIST criteria was performed for 48 tumors that had follow-up scans. There were 21 responders (mean dose 215 Gy) and 27 non-responders (mean dose 167 Gy). The association between mean tumor absorbed dose and response suggests a trend but did not reach statistical significance (p = 0.099). Normal liver tissue received a mean dose of 67 Gy (mode 60-70 Gy; range 10-120 Gy). There was a statistically significant association between absorbed dose to normal liver and the presence of two or more severe complications (p = 0.036). CONCLUSION: Our cohort of patients showed a possible dose-response trend for the tumors. Collateral dose to normal liver is non-trivial and can have clinical implications. These methods help us understand whether patient adverse events, treatment success, or treatment failure can be attributed to the dose that the tumor or normal liver received